Showing results (101-110 of 128) with videos related to
Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|June 1, 2017
Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitorsLing Tong, Seong Heon Kim, Kristin Rosner, et al.ACS Medicinal Chemistry Letters|August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) InhibitorsQinglin Pu, Hongjun Zhang, Liangqin Guo, et al.ACS Medicinal Chemistry Letters|October 16, 2024
Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase InhibitorsSriram Tyagarajan, Christine L Andrews, Douglas C Beshore, et al.Journal of Medicinal Chemistry|April 24, 2018
Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated SubstitutionsWensheng Yu, Ling Tong, Oleg Selyutin, et al.Bioorganic & Medicinal Chemistry Letters|September 17, 2016
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.Bioorganic & Medicinal Chemistry Letters|October 25, 2011
III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffoldSeong Heon Kim, Gopinadhan N Anilkumar, Lisa Guise Zawacki, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2018
MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCVAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer ImmunotherapyHongjun Zhang, Kun Liu, Qinglin Pu, et al.Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitorsWensheng Yu, Ling Tong, Seong Heon Kim, et al.Pageof 13